Former Congressman Colin Allred delivers a pointed public rebuke of Texas House member James Talarico, alleging derogatory comments were made during the heated Democratic Senate primary campaign.
A broad sell-off in risk assets, from equities to precious metals, has triggered over $2.5 billion in Bitcoin liquidations. Analysts point to shifting Federal Reserve expectations and AI trade anxieties as key drivers behind the latest crypto market tremor.
CNBC's Jim Cramer concedes he misjudged the explosive demand for Apple's iPhone 17, which powered the tech giant to a staggering earnings beat that caught Wall Street off guard.
The Priestly Society of St. Pius X (SSPX) announced plans to consecrate new bishops in July without Vatican approval, escalating a decades-long doctrinal standoff and prompting concerns of a permanent rupture within the Catholic Church.
The rapid adoption of algorithmic decision-making in UK banks has created a critical lag in oversight and accountability structures, leaving institutions exposed to risks that traditional governance models are ill-equipped to manage.
AbbVie's stock presents a complex picture for investors, with recent mixed performance contrasting sharply with its robust multi-year returns. As shares trade below consensus targets, the market weighs near-term headwinds against the pharmaceutical giant's proven track record and pipeline potential.
Goldman Sachs' investment arm leads a major funding round in Fieldguide, an AI platform for auditors and accountants, signaling a strategic push into the automation of professional services and a potential new growth vector for the Wall Street giant.
As the ASX braces for a turbulent February amid rate hike fears, a closer look reveals resilient micro-caps with unique value propositions. We analyze three sub-$150M companies—from healthcare tech to critical minerals—that are navigating the volatility with strong balance sheets and niche market positions.
Despite a significant weekly drop in market valuation, G Mining Ventures' substantial institutional ownership and strong yearly returns suggest major investors are focused on the long game, even as recent volatility raises questions.
The retail-focused trading platform saw its stock drop sharply Monday, dragged down by a weekend cryptocurrency sell-off that threatens to dampen user activity and near-term growth prospects.
Sources indicate Disney's board is finalizing plans to appoint theme parks chairman Josh D’Amaro as the company's next chief executive, concluding a lengthy succession search. The move would place the profitable parks division veteran at the helm of the global entertainment giant.
Disney shares fell sharply after the company flagged weakening attendance from overseas guests at its U.S. theme parks, a crucial profit driver, alongside softer results in its TV and film division. The dip comes amid a broader slowdown in travel to the United States and as the entertainment giant prepares for a pivotal CEO transition.
Ukraine's defense minister confirms collaborative efforts with SpaceX have yielded initial success in countering Russia's unauthorized use of Starlink terminals to guide attack drones, with a new verification system imminent.
Thai military officials have revealed a massive cache of evidence, including scam scripts and fake police setups, seized from a contested border compound in Cambodia, shedding light on the scale of transnational cyber fraud operations in the region.
Russia's Foreign Ministry issued a stark warning on Monday, stating any deployment of foreign military forces or infrastructure in Ukraine would be considered an intervention, making those forces lawful targets for Russian strikes.
The surge in popularity of weight-loss drugs like Ozempic and Wegovy is sending shockwaves far beyond the pharmacy, fundamentally altering consumer spending, challenging major corporations, and forcing a broad economic recalibration.
CNBC's Jim Cramer issues a stark warning on Bitcoin's volatility, predicting a key support level while questioning MicroStrategy's Michael Saylor. Amid a sharp sell-off, Saylor's firm continues its aggressive accumulation strategy.
A criminal probe into outgoing Fed Chair Jerome Powell, initiated by the Trump administration, has triggered a Senate blockade led by a key Republican. The standoff jeopardizes Kevin Warsh's confirmation and risks delaying the interest rate cuts Trump desires ahead of a tough election.
Crude oil and gasoline futures tumbled sharply on Thursday, pressured by a surging U.S. dollar and signs of diplomatic progress between the U.S. and Iran. The sell-off erases recent geopolitical risk premiums, with increased supply from Venezuela adding further downward momentum.
IDEAYA Biosciences shares have retreated from recent highs, sparking debate among investors. While a discounted cash flow model suggests deep undervaluation, price-to-sales metrics paint a contrasting picture of a premium stock. We examine the numbers behind the volatility and what it signals for the precision oncology company's future.
